New analysis highlights BOT/BAL activity across challenging metastatic disease sites Contacts Investors 917-362-1370 investor@agenusbio.com Media 917-362-1370 communications@agenusbio.com Agenus Inc. (“Agenus”)...
MANNHEIM, Germany, May 23, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients...
Administration of azenosertib combined with gemcitabine was well tolerated and resulted in clinically meaningful increase in event-free survival compared to...
83% (5/6) of patients achieved a confirmed partial response in cohort 1, the most mature dose level; one dose-limiting toxicity...
MONTRÉAL, 23 mai 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une entreprise biopharmaceutique axée...
SOUTH SAN FRANCISCO, Calif., May 23, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced upcoming presentations from their...
WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the...
Oral presentation to highlight activity of REGN7075 in combination with Libtayo from dose-escalation portion of trial in patients with microsatellite...
GERMANTOWN, Md., May 23, 2024 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene...
SANTA CLARA, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- NVIDIA will present at the following event for the financial community:BofA...
SNK02 has the potential to be a first-in-class cryopreserved allogeneic NK cell therapy for solid tumors that does not require...
ARTISTRY-3 trial is being conducted to evaluate less frequent dosing of nemvaleukin alfa, Mural’s late-stage lead candidateNemvaleukin demonstrated pharmacodynamic proof...
MCLA-145 monotherapy and in combination with pembrolizumab rapid oral session presentation: June 2, 2024, 11:30 a.m.-1:00 p.m. CTUTRECHT, The Netherlands...
Miami, Florida and Austin, Texas, May 23, 2024 (GLOBE NEWSWIRE) -- Maquia Capital Acquisition Corporation, a special purpose acquisition company...
Miami, Florida and Austin, Texas, May 23, 2024 (GLOBE NEWSWIRE) -- Maquia Capital Acquisition Corporation, a special purpose acquisition company...
Contacts For Ligand: Investors: Michael Jeong investors@ligand.com (561) 214-4232 LifeSci Advisors Bob Yedid bob@lifesciadvisors.com (516) 428-8577 Media: Kellie Walsh media@ligand.com...
First disclosure from Cohort D of the Phase 2 CARTITUDE-2 study investigating CARVYKTI® in patients who had suboptimal response to...
Abstract released today highlights safety, pharmacodynamic and clinical response data with additional data to be presented in a poster session...
HALIFAX, Nova Scotia, May 23, 2024 (GLOBE NEWSWIRE) -- ELCORA ADVANCED MATERIALS CORP. (TSX.V:ERA | Frankfurt:ELM | OTCQB – ECORF), (the "Company"...
Lifileucel TIL Cell Therapy in Combination with Pembrolizumab DemonstratesDeep, Durable Responses in Frontline Advanced Melanoma Patientsin IOV-COM-202 Clinical StudyRead more...
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T...
- Updated single agent dose escalation data continues to demonstrate that WTX-124 is well tolerated and clinically active in patients...
NEW YORK and VIENNA, May 23, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a...
Six oral and poster presentations will highlight breadth of clinical program and potential utility of epcoritamab-bysp in patients with difficult-to-treat...
COPENHAGEN, Denmark, May 23, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio...
Miami, Florida and Austin, Texas, May 23, 2024 (GLOBE NEWSWIRE) -- Maquia Capital Acquisition Corporation, a special purpose acquisition company...
Miami, Florida and Austin, Texas, May 23, 2024 (GLOBE NEWSWIRE) -- Maquia Capital Acquisition Corporation, a special purpose acquisition company...
Miami, Florida and Austin, Texas, May 23, 2024 (GLOBE NEWSWIRE) -- Maquia Capital Acquisition Corporation, a special purpose acquisition company...
Highest Quarterly and Annual Revenue in Company History MIDLAND, VA / ACCESSWIRE / May 23, 2024 / Smith-Midland Corporation (NASDAQ:SMID),...
TEL AVIV, Israel, May 23, 2024 (GLOBE NEWSWIRE) -- via IBN – HUB Cyber Security Ltd. (Nasdaq: HUBC), a developer of...
Millicom (Tigo) comments on shareholder communicationLuxembourg, May 23, 2024 – The Board of Directors of Millicom International Cellular S.A. (“Millicom”)...
Contacts Media Rick Castellano 302.451.2541 rick.castellano@salliemae.com Investors Melissa Bronaugh 571.526.2455 melissa.bronaugh@salliemae.com Sallie Mae® (Nasdaq: SLM), formally SLM Corporation, today announced...
ALEXANDRIA, La., May 23, 2024 (GLOBE NEWSWIRE) -- Red River Bancshares, Inc. (Nasdaq: RRBI) (the “Company”) announced today that on...
MUNICH, Germany, May 23, 2024 (GLOBE NEWSWIRE) -- Lilium N.V. (NASDAQ: LILM) (“Lilium” or the “Company”), developer of the first...
HAUPPAUGE, N.Y., May 23, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent...
HAUPPAUGE, N.Y., May 23, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent...
Contacts Investor Relations Cadence Design Systems, Inc. 408-944-7100 investor_relations@cadence.com Cadence Design Systems, Inc. (Nasdaq: CDNS): WHO: Anirudh Devgan, president and...
DENVER, May 23, 2024 (GLOBE NEWSWIRE) -- Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (“CPH” or the “Company”), a leading provider...
Contacts Al Villalon, Investor Relations 952.417.3733 Al.Villalon@alerus.com investors.alerus.com Alerus Financial Corporation (NASDAQ: ALRS) announced that its board of directors declared...
LONGMONT, Colo., May 23, 2024 /PRNewswire/ -- S&W Seed Company (Nasdaq: SANW) announced today that Mark Herrmann, CEO, will participate in...
